Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Metal-on-metal hip implant study finds no cancer link at 7 years
Metal-on-metal hip implants, the subject of a handful of high-profile recalls and numerous patient lawsuits, were not linked with an early increase in cancer risk, according to a 7-year study of the U.K.’s National Joint Registry.
2. ‘Financial Armageddon’ would slash $11B from docs’ Medicare pay
More than $110 billion in mandatory budget cuts are slated for next year in a so-called ‘financial Armageddon’ called sequestration, including $11 billion in Medicare reimbursements cuts for physicians and healthcare providers.
1. U.K. urges docs to monitor St. Jude’s recalled Riata leads
U.K. regulators warn physicians to remain vigilant in monitoring patients implanted with St. Jude Medical’s recalled Riata and Riata ST silicone-coated pacemaker wires.
